Welgene Biotech Co.,Ltd. (TPEX:6661)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.15
-0.15 (-0.82%)
Apr 29, 2026, 1:30 PM CST

Welgene Biotech Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
224.33173.5188.13158.59199.77
Upgrade
Short-Term Investments
435395921
Upgrade
Trading Asset Securities
----2.72
Upgrade
Cash & Short-Term Investments
267.33226.5197.13217.59223.49
Upgrade
Cash Growth
18.03%14.90%-9.40%-2.64%23.24%
Upgrade
Accounts Receivable
46.745.5846.9846.5782.86
Upgrade
Other Receivables
1.43.613.240.754.28
Upgrade
Receivables
48.0949.1950.2347.3187.14
Upgrade
Inventory
39.0836.8853.7733.9826.99
Upgrade
Prepaid Expenses
4.635.964.452.462.74
Upgrade
Other Current Assets
4.691.70.710.860.77
Upgrade
Total Current Assets
363.83320.22306.28302.2341.13
Upgrade
Property, Plant & Equipment
234.45174.88198.8278.6330.67
Upgrade
Long-Term Investments
17.6126.1233.9842.0941.36
Upgrade
Other Intangible Assets
0.650.160.390.731.07
Upgrade
Long-Term Deferred Tax Assets
0.510.440.560.490.69
Upgrade
Other Long-Term Assets
5.156.428.1311.579.62
Upgrade
Total Assets
622.19528.25548.16435.71424.54
Upgrade
Accounts Payable
25.1716.9117.3718.9912.53
Upgrade
Accrued Expenses
-24.2821.1825.0226.61
Upgrade
Short-Term Debt
1291111.2112.56
Upgrade
Current Portion of Long-Term Debt
28.5411.6811.05--
Upgrade
Current Portion of Leases
14.5513.5813.3313.0811.28
Upgrade
Current Income Taxes Payable
-0.36-2.44-
Upgrade
Current Unearned Revenue
54.256.1346.1829.4546.53
Upgrade
Other Current Liabilities
29.954.667.844.514.71
Upgrade
Total Current Liabilities
164.4136.59127.94104.71114.22
Upgrade
Long-Term Debt
141.1995.58105.4--
Upgrade
Long-Term Leases
30.25-13.5826.9-
Upgrade
Pension & Post-Retirement Benefits
---0.120.24
Upgrade
Long-Term Deferred Tax Liabilities
0.260.320.30.030.02
Upgrade
Other Long-Term Liabilities
0.020.020.68--
Upgrade
Total Liabilities
336.12232.5247.89131.76114.47
Upgrade
Common Stock
233.04233.04233.04233.04233.04
Upgrade
Additional Paid-In Capital
50.9350.8650.8650.8650.86
Upgrade
Retained Earnings
21.2920.6219.5127.1828.88
Upgrade
Comprehensive Income & Other
-23.97-16.61-11.38-7.32-2.92
Upgrade
Total Common Equity
281.3287.91292.03303.76309.86
Upgrade
Minority Interest
4.787.848.240.20.21
Upgrade
Shareholders' Equity
286.07295.75300.27303.95310.06
Upgrade
Total Liabilities & Equity
622.19528.25548.16435.71424.54
Upgrade
Total Debt
226.53129.83154.3551.1923.84
Upgrade
Net Cash (Debt)
40.896.6642.78166.4199.64
Upgrade
Net Cash Growth
-57.79%125.94%-74.29%-16.65%31.38%
Upgrade
Net Cash Per Share
1.844.151.847.138.64
Upgrade
Filing Date Shares Outstanding
18.7523.323.323.323.3
Upgrade
Total Common Shares Outstanding
18.7523.323.323.323.3
Upgrade
Working Capital
199.43183.63178.34197.49226.92
Upgrade
Book Value Per Share
15.0012.3512.5313.0313.30
Upgrade
Tangible Book Value
280.65287.75291.64303.03308.79
Upgrade
Tangible Book Value Per Share
14.9612.3512.5113.0013.25
Upgrade
Land
-22.7622.76--
Upgrade
Buildings
-97.797.7--
Upgrade
Machinery
-93.49107.4677.255.9
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.